Prophylactic Effect of Monoclonal Antibody 1D2 Administration in a Mouse Model of Invasive Aspergillosis
Open Access
- 6 November 2026
- journal article
- research article
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (11) , 835
Abstract
Objective: To investigate the prophylactic efficacy of monoclonal antibody (mAb) 1D2 against Aspergillus fumigatus in an immunosuppressed mouse model of invasive aspergillosis (IA). Methods: BALB/c mice (n = 18) were immunosuppressed with cyclophosphamide and randomly assigned into three groups (n = 6 each): 1D2 prophylaxis, isotype antibody (6B10) control and PBS control. Two hours prior to intravenous inoculation of A. fumigatus conidia (2 × 105 conidia per mouse), 1D2 (100 μg) or control interventions were administered intravenously. Clinical signs and body weight were monitored, and mice were euthanised for tissue and blood collection 48 h after infection. Liver injury was assessed histologically using a modified semi-quantitative scoring system. Fungal burden was assessed by colony-forming unit (CFU) counts in blood and sampled liver, spleen, kidney, and lung tissues. Plasma cytokine concentrations were analysed by ELISA. Results: 1D2-treated mice showed a lower loss of body weight post-inoculation than PBS controls (p = 0.007) and had significantly reduced clinical distress scores on days 1 and 2 (p < 0.05). Histopathological analysis showed alleviated liver injury in the 1D2 group, with a median liver injury score of 4.5 (IQR 3.0–5.25) versus 8.0 (IQR 6.75–10.0) in PBS controls (p < 0.05). CFU counts in the liver, spleen and kidney were significantly lower in the 1D2-treated group than in either control group (p < 0.05). Plasma IL-6 levels were reduced in the 1D2-treated group (582.9 ± 279.7 pg/mL) compared with PBS (1073 ± 289.1 pg/mL) and 6B10 (1080 ± 357.4 pg/mL)-treated controls (p < 0.05). TNF-α and IL-1 showed no significant differences. Conclusions: Prophylactic administration of mAb 1D2 was associated with reduced post-inoculation weight loss, lower clinical distress scores, less liver injury, and reduced recoverable CFU counts in sampled liver, spleen and kidney tissues. Plasma IL-6 concentrations were also lower in the 1D2-treated group. These findings provide proof-of-concept evidence supporting further preclinical evaluation of 1D2 as a prophylactic candidate against IA.Keywords
Funding Information
- University of Otago Sandy Smith Scholarship/Grants-in-Aid
- McGee Fellowship 2023
- University of Otago Research Grant
- Canterbury Medical Research Foundation
- Maurice and Phyllis Paykel Trust
- Joint Funds for the Innovation of Science and Technology, Fujian province (2023Y9264)
This publication has 25 references indexed in Scilit:
- Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)Leukemia, 2025
- Invasive aspergillosis: A comprehensive reviewMedicina Clinica, 2024
- Global incidence and mortality of severe fungal diseaseThe Lancet Infectious Diseases, 2024
- Pathogenicity and virulence of Aspergillus fumigatusVirulence, 2023
- Association between early diagnosis of and inpatient mortality from invasive pulmonary aspergillosis among patients without immunocompromised host factors: a nationwide observational studyInternational Journal of Infectious Diseases, 2022
- The role of Glabridin in antifungal and anti-inflammation effects in Aspergillus fumigatus keratitisExperimental Eye Research, 2022
- A novel monoclonal antibody against enolase antigen ofAspergillus fumigatusprotects experimental aspergillosis in miceFEMS Microbiology Letters, 2019
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2016
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) DatabaseClinical Infectious Diseases, 2010
- The half-lives of serum immunoglobulins in adult miceEuropean Journal of Immunology, 1988